The Global Fund to Fight AIDS, Tuberculosis and Malaria
Overview
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing and partnership organization that raises and invests funds to support programs aimed at ending the epidemics of HIV/AIDS, tuberculosis, and malaria.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Emergency Response Africa | - | Grant | Co-investor |
| Aide Chemists | Mar 2025 | Accelerator | Co-investor |
| MedTrack | Sep 2024 | Grant | Co-investor |
| HealthX Africa | - | Grant | Co-investor |
| Afya Intelligence | Jul 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Key People
Peter Sands
Executive Director
Blanca Gil Antunano
Fund Portfolio Manager
Blanca Gil Antuñano
Fund Portfolio Manager
Bruno Viana
Fund Portfolio Manager
Carmen Gonzalez
Portfolio Manager
George Sakvarelidze
Senior Fund Portfolio Manager
Hans Zweschper
Fund Portfolio Manager
Karina Halle
Fund Portfolio Manager
Lilian Pedrosa
Senior Portfolio Fund Manager - Burkina Faso, Fund Portfolio Manager
Mark Willis
Fund Portfolio Manager, West and Central Africa, Fund Portfolio Manager
Paul Bonilla
Fund Portfolio Manager
Qi Cui
Senior Fund Portfolio Manager
Sandra Irbe
Senior Fund Portfolio Manager
Saran FADIGA-BRANCHI
Senior Fund Portfolio Manager
Sonia Florisse
Fund Portfolio Manager
Tatjana Peterson
Senior Fund Portfolio Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The Global Fund to Fight AIDS, Tuberculosis and Malaria based?
The Global Fund to Fight AIDS, Tuberculosis and Malaria is headquartered in Geneva, Switzerland.
When was The Global Fund to Fight AIDS, Tuberculosis and Malaria founded?
The Global Fund to Fight AIDS, Tuberculosis and Malaria was founded in 2002.
How many portfolio companies does The Global Fund to Fight AIDS, Tuberculosis and Malaria have?
The Global Fund to Fight AIDS, Tuberculosis and Malaria has 10 portfolio companies in Caplight's dataset.
What are some companies in The Global Fund to Fight AIDS, Tuberculosis and Malaria's portfolio?
Portfolio companies visible on Caplight include Emergency Response Africa, Aide Chemists, MedTrack, HealthX Africa, Afya Intelligence.
What was The Global Fund to Fight AIDS, Tuberculosis and Malaria's most recent investment shown here?
The Global Fund to Fight AIDS, Tuberculosis and Malaria's most recent investment in this portfolio sample was in Aide Chemists in 2025.
What sectors does The Global Fund to Fight AIDS, Tuberculosis and Malaria focus on?
The Global Fund to Fight AIDS, Tuberculosis and Malaria focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, Enterprise Software, Enterprise Software, Enterprise Software, Consumer & Commerce, Enterprise Software, Consumer & Commerce, Enterprise Software, Consumer & Commerce.
What company stages does The Global Fund to Fight AIDS, Tuberculosis and Malaria focus on?
The Global Fund to Fight AIDS, Tuberculosis and Malaria typically invests at the MultiStage stage.
What is The Global Fund to Fight AIDS, Tuberculosis and Malaria's AUM?
The Global Fund to Fight AIDS, Tuberculosis and Malaria's assets under management are estimated between $78.6B and $78.6B.